APA (7th ed.) Citation

Batouche, A., Czeizler, E., Lehto, T., Erickson, A., Shadbahr, T., Laajala, T. D., . . . Rannikko, A. S. (2026). Comparable recurrence risk for MRI‐detected Gleason Grade Group (GG) 2 and systematic biopsy‐detected GG1 prostate cancer. BJU International, 137(3), 547. https://doi.org/10.1111/bju.70109

Chicago Style (17th ed.) Citation

Batouche, Abderrahim‐Oussama, Eugen Czeizler, Timo‐Pekka Lehto, Andrew Erickson, Tolou Shadbahr, Teemu D. Laajala, Joona Pohjonen, Tuomas Mirtti, and Antti S. Rannikko. "Comparable Recurrence Risk for MRI‐detected Gleason Grade Group (GG) 2 and Systematic Biopsy‐detected GG1 Prostate Cancer." BJU International 137, no. 3 (2026): 547. https://doi.org/10.1111/bju.70109.

MLA (9th ed.) Citation

Batouche, Abderrahim‐Oussama, et al. "Comparable Recurrence Risk for MRI‐detected Gleason Grade Group (GG) 2 and Systematic Biopsy‐detected GG1 Prostate Cancer." BJU International, vol. 137, no. 3, 2026, p. 547, https://doi.org/10.1111/bju.70109.